Chuandong Zhu

1-1 Zhongfu Road
Nanjing, 210003, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Tumor mRNA-lipid nanoparticles via chimeric nanobody-lipid co-assembly.

Tumor mRNA-lipid nanoparticles via chimeric nanobody-lipid co-assembly.

Journal: Theranostics
Published: August 12, 2025

Polarization of Tumor Cells and Tumor-Associated Macrophages: Molecular Mechanisms and Therapeutic Targets.

Polarization of Tumor Cells and Tumor-Associated Macrophages: Molecular Mechanisms and Therapeutic Targets.

Journal: MedComm
Published: April 21, 2025

Enhanced detection of circulating tumor cells using a MUC1 promoter-driven recombinant adenovirus.

Enhanced detection of circulating tumor cells using a MUC1 promoter-driven recombinant adenovirus.

Journal: Frontiers in oncology
Published: October 06, 2024

Multi-level insights into the immuno-oncology-microbiome axis: From biotechnology to novel therapies.

Multi-level insights into the immuno-oncology-microbiome axis: From biotechnology to novel therapies.

Journal: iMeta
Published: August 10, 2024

MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3.

MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3.

Journal: Cancer biology & therapy
Published: July 05, 2024

Identifying Factors Affecting the Survival of Patients with HIV-Associated B-Cell Lymphoma Using a Random Survival Forest Model.

Identifying Factors Affecting the Survival of Patients with HIV-Associated B-Cell Lymphoma Using a Random Survival Forest Model.

Journal: Clinical Medicine Insights. Oncology
Published: April 17, 2024

Tumor-derived extracellular vesicles as a biomarker for breast cancer diagnosis and metastasis monitoring.

Tumor-derived extracellular vesicles as a biomarker for breast cancer diagnosis and metastasis monitoring.

Journal: iScience
Published: November 20, 2023

Expanding the applications of immune checkpoint inhibitors in advanced lung cancer beyond disease progression.

Expanding the applications of immune checkpoint inhibitors in advanced lung cancer beyond disease progression.

Journal: Frontiers in immunology
Published: July 25, 2023

Chimeric nanobody-decorated liposomes by self-assembly.

Chimeric nanobody-decorated liposomes by self-assembly.

Journal: Nature nanotechnology
Published: May 05, 2023

YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer.

YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer.

Journal: Journal of thoracic disease
Published: January 03, 2023

CPSF6-mediated XBP1 3'UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma.

CPSF6-mediated XBP1 3'UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: November 03, 2022

Engineered extracellular vesicles for concurrent Anti-PDL1 immunotherapy and chemotherapy.

Engineered extracellular vesicles for concurrent Anti-PDL1 immunotherapy and chemotherapy.

Journal: Bioactive materials
Published: June 07, 2021
Showing 1-12 of 19

Last Updated: 09/26/2026